| Brand | BD Pharmingen™ |
|---|---|
| Alternative Name | ICAM-1; intercellular adhesion molecule 1; BB2; P3.58 |
| Reactivity | Human (QC Testing) |
| Isotype | Mouse BALB/c IgG1, κ |
| Immunogen | IFN-γ-treated BM314 colonic carcinoma cells |
| Application | Flow cytometry (Routinely Tested) |
| Vol. Per Test | 20 µl |
| Workshop Number | VI A095 |
| RRID | AB_395901 |
| Storage Buffer | Aqueous buffered solution containing BSA and ≤0.09% sodium azide. |
| Regulatory Status | RUO |
Answer:CD54, also known as ICAM-1.
Answer:Mouse monoclonal clone HA58 with PE conjugation.
Answer:100 tests.
BD Pharmingen PE Mouse Anti-Human CD54 is a phycoerythrin-conjugated monoclonal antibody for detecting the human CD54 adhesion molecule by flow cytometry. Mouse clone HA58 binds CD54, also called intercellular adhesion molecule 1 (ICAM-1), a cell-surface protein involved in leukocyte adhesion and immune-cell interactions. CD54 expression can be assessed on activated immune cells and other human cell populations in inflammation, activation and cell-phenotyping experiments. The PE fluorescent tag provides a bright signal for use in compatible flow cytometer detection channels. This prediluted, 100-test format supports direct staining in laboratory immunophenotyping panels and can be paired with a PE mouse IgG1 κ isotype control where appropriate. The reagent is for research use only and is stored refrigerated without freezing.
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.